FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frieder Keller

Research Profile

Disorders

Chemicals & Drugs

Procedures

Renal Dialysis

Physiology

Pharmacokinetics

Concepts & Ideas

Anatomy

Phenomena

Metabolic Clearance Rate

Co-author Network

Publications

TOP 3
Frieder Keller; Donald Bunjes; Bertram Hartmann; Susanne Wiesner; Michael Schmitt
Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation.
Frieder Keller
Drug use in the intensive care unit.
David Czock; Frieder Keller; Hanna M Seidling
Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frieder Keller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Frieder Keller; Donald Bunjes; Bertram Hartmann; Susanne Wiesner; Michael Schmitt
Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation.
Annals of transplantation : quarterly of the Polish Transplantation Society 2012;17(4):52-8.
2012: Frieder Keller
Drug use in the intensive care unit.
Kidney international 2012;82(8):936; author reply 936-7.
2012: David Czock; Frieder Keller; Hanna M Seidling
Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs.
British journal of clinical pharmacology 2012;74(1):66-74.
2012: Philipp Hoffmann; Frieder Keller
Increased major bleeding risk in patients with kidney dysfunction receiving enoxaparin: a meta-analysis.
European journal of clinical pharmacology 2012;68(5):757-65.
2012: Sylvia Stracke; Liying Yang; Amir Zarghom; Doris Henne-Bruns; Frieder Keller; Jens Mayer; Maria Shipkova; Eberhard Wieland
Pharmacokinetics and pharmacodynamics of mycophenolate sodium (EC-MPS) co-administered with cyclosporine in the early-phase post-kidney transplantation.
Clinical transplantation 2012;26(1):57-66.
2011: Sebastian Maus; Frieder Keller
[Common errors in pharmacotherapy of patients with chronic kidney disease].
MMW Fortschritte der Medizin 2011;153(16):39-42.
2010: Sebastian Maus; Caecilia Holch; David Czock; Florian Thalhammer; Frieder Keller; Bertram Hartmann
[Questionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function].
Wiener klinische Wochenschrift 2010;122(15-16):479-85.
2010: C Aymanns; Frieder Keller; Sebastian Maus; Bertram Hartmann; David Czock
Review on pharmacokinetics and pharmacodynamics and the aging kidney.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(2):314-27.
2009: M Koelch; A Prestel; H Singer; Frieder Keller; Jörg M Fegert; R Schlack; H Hoelling; H Knopf
Psychotropic medication in children and adolescents in Germany: prevalence, indications, and psychopathological patterns.
Journal of child and adolescent psychopharmacology 2009;19(6):765-70.
2009: P L Plener; Gerhard Libal; Frieder Keller; Jörg M Fegert; J J Muehlenkamp
An international comparison of adolescent non-suicidal self-injury (NSSI) and suicide attempts: Germany and the USA.
Psychological medicine 2009;39(9):1549-58.
2009: Sebastian Oliver Decker; Frieder Keller; Jens Mayer; Sylvia Stracke
Twice daily fractionated dose administration of prednisolone compared to standard once daily administration to patients with glomerulonephritis or with kidney transplants.
Medizinische Klinik (Munich, Germany : 1983) 2009;104(6):429-33.
2009: Frieder Keller; Bertram Hartmann; David Czock
Mean residence time as estimated from cropped and truncated moments.
Arzneimittel-Forschung 2009;59(7):377-81.
2007: David Czock; Frieder Keller
Mechanism-based pharmacokinetic-pharmacodynamic modeling of antimicrobial drug effects.
Journal of pharmacokinetics and pharmacodynamics 2007;34(6):727-51.
2007: Frieder Keller; Harald Dress; Andreas Mertz; Georg Marckmann
[Financial incentives and dialysis].
Medizinische Klinik (Munich, Germany : 1983) 2007;102(8):659-64.
2007: Sylvia Stracke; Klaus Konner; Isabella Köstlin; Markus Schneider; Rosa Herzog; Peter M Jehle; Frieder Keller; Reinhard Friedl
Over-expression of IGF-related peptides in stenoses of native arteriovenous fistulas in hemodialysis patients.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2007;17(4):297-306.
2007: David Czock; Franz Maximilian Rasche; Alexander Carius; Petra Glander; Klemens Budde; Steffen Bauer; Frieder Keller; Lutz Von Müller
Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
Journal of clinical pharmacology 2007;47(7):850-9.
2007: Franz Maximilian Rasche; Frieder Keller; G Kunze; B Boesler; David Czock
Single daily dose of cyclosporine in patients with primary glomerulonephritis and nephrotic syndrome.
Clinical nephrology 2007;67(5):285-92.
2007: Frieder Keller; U Winkler; J Mayer; Sylvia Stracke
Should commercial organ donation be legalized in Germany? An ethical discourse.
Transplantation proceedings 2007;39(2):475-7.
2007: Pars Tuncyurek; J M Mayer; F Klug; S Dillmann; Doris Henne-Bruns; Frieder Keller; Sylvia Stracke
Everolimus and mycophenolate mofetil sensitize human pancreatic cancer cells to gemcitabine in vitro: a novel adjunct to standard chemotherapy?
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 2007;39(6):380-7.
2007: Franz Maximilian Rasche; Frieder Keller; Lutz Von Müller; David Czock; Philipp Lepper
Sequential immunosuppressive therapy in progressive IgA nephropathy.
Contributions to nephrology 2007;157():109-13.
2006: C Aymanns; M Voehringer; Franz Maximilian Rasche; Frieder Keller
Effects of sirolimus on proteinuria and renal function in focal segmental glomerulonephritis.
International journal of clinical pharmacology and therapeutics 2006;44(12):675-6.
2006: David Czock; Cordula Hüsig-Linde; Anita Langhoff; Timo Schöpke; Carsten Hafer; Kirsten de Groot; Stefanie Swoboda; Ernst Kuse; Hermann Haller; Danilo Fliser; Frieder Keller; Jan T Kielstein
Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
Clinical journal of the American Society of Nephrology : CJASN 2006;1(6):1263-8.
2006: Franz Maximilian Rasche; Frieder Keller; Philipp Lepper; C Aymanns; Wolfram Karges; L-C Sailer; L von Müller; David Czock
High-dose intravenous immunoglobulin pulse therapy in patients with progressive immunoglobulin A nephropathy: a long-term follow-up.
Clinical and experimental immunology 2006;146(1):47-53.
2006: Franz Maximilian Rasche; Frieder Keller; Lutz Von Müller; Leif-Konradin Sailer; Wolfram Karges; David Czock
Mycophenolic acid therapy after cyclophosphamide pulses in progressive IgA nephropathy.
Journal of nephrology 2006;19(4):465-72.
2006: Sylvia Stracke; L Ramudo; Frieder Keller; Doris Henne-Bruns; J M Mayer
Antiproliferative and overadditive effects of everolimus and mycophenolate mofetil in pancreas and lung cancer cells in vitro.
Transplantation proceedings 2006;38(3):766-70.
2006: B Rehm; Frieder Keller; J Mayer; Sylvia Stracke
Resolution of sirolimus-induced pneumonitis after conversion to everolimus.
Transplantation proceedings 2006;38(3):711-3.
2006: Thorsten Zenz; Richard F Schlenk; Gerhard Glatting; Bernd Neumaier; Norbert M Blumstein; Inga Buchmann; Stephanie von Harsdorf; Mark Ringhoffer; Markus Wiesneth; Frieder Keller; Jörg Kotzerke; Erwin M Röttinger; Stephan Stilgenbauer; Hartmut Döhner; Sven N Reske; Donald Bunjes
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(2):278-86.
2006: Jan T Kielstein; David Czock; Timo Schöpke; Carsten Hafer; Stefanie M Bode-Böger; Ernst Kuse; Frieder Keller; Danilo Fliser
Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.
Critical care medicine 2006;34(1):51-6.
2005: David Czock; U Häussler; C Aymanns; Frieder Keller
[Nephrotoxic drugs].
Deutsche medizinische Wochenschrift (1946) 2005;130(45):2579-84; quiz 2585-6.
2005: Franz Maximilian Rasche; Frieder Keller; David Czock
[Chemotherapy in patients with renal failure, dialysis and after transplantation].
Deutsche medizinische Wochenschrift (1946) 2005;130(36):2043-6.
2005: Benjamin Boesler; David Czock; Frieder Keller; Martin Griesshammer; Thomas Seufferlein; Wolfram Karges; Franz Maximilian Rasche
Clinical course of haemodialysis patients with malignancies and dose-adjusted chemotherapy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(6):1187-91.
2005: David Czock; Frieder Keller; Mette Heringa; Franz Maximilian Rasche
Raloxifene pharmacokinetics in males with normal and impaired renal function.
British journal of clinical pharmacology 2005;59(4):479-82.
2005: David Czock; Frieder Keller; Franz Maximilian Rasche; Ulla Häussler
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Clinical pharmacokinetics 2005;44(1):61-98.
2004: Franz Maximilian Rasche; Leif-Conradin Sailer; David Czock; Frieder Keller
Tonsillectomy, high dose immunoglobulins, and cyclophosphamide in progressive IgA-nephropathy.
Acta oto-laryngologica. Supplementum 2004;(555):32-7.
2004: Christian Aymanns; Frieder Keller
[Drug dosage in renal failure -- traps and aids].
Medizinische Klinik (Munich, Germany : 1983) 2004;99(10):613-24; quiz 625.
2004: Franz Maximilian Rasche; Boris Uhel; Detlev H Krüger; Wolfram Karges; David Czock; Walter Hampl; Frieder Keller; Helga Meisel; Lutz Von Müller
Thrombocytopenia and acute renal failure in Puumala hantavirus infections.
Emerging infectious diseases 2004;10(8):1420-5.
2004: Ulla Haeussler; Martin Riedel; Frieder Keller
Free reactive oxygen species and nephrotoxicity of contrast agents.
Kidney & blood pressure research 2004;27(3):167-71.
2004: Peter J Heering; Norbert Braun; Reinhard Müllejans; Katrin Ivens; Ingeborg Zäuner; Reinhard Fünfstück; Frieder Keller; Bernhard K Krämer; Peter Schollmeyer; Teut Risler; Bernd Grabensee
Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(1):10-8.
2003: Sylvia Stracke; Udo Helmchen; Lutz Von Müller; Donald Bunjes; Frieder Keller
Polyoma virus-associated interstitial nephritis in a patient with acute myeloic leukaemia and peripheral blood stem cell transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(11):2431-3.
2003: Franz Maximilian Rasche; Christoph Hubert Klotz; David Czock; Wolfram Karges; Rainer Muche; Peter M Jehle; Andreas Mertz; Frieder Keller
Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
Nephron. Clinical practice 2003;93(4):c131-6.
2002: David Czock; Cornelia Scholle; Franz Maximilian Rasche; Dieter Schaarschmidt; Frieder Keller
Pharmacokinetics of valganciclovir and ganciclovir in renal impairment.
Clinical pharmacology and therapeutics 2002;72(2):142-50.
2002: A Uhl; David Czock; B-O Boehm; D Zellner; Andreas Mertz; Frieder Keller
Pharmacokinetics and pharmacodynamics of methylprednisolone after one bolus dose compared with two dose fractions.
Journal of clinical pharmacy and therapeutics 2002;27(4):281-7.
2002: Cornelia Blume; Katrin Ivens; Philip May; Udo Helmchen; Peter M Jehle; M Riedel; Frieder Keller; Bernd Grabensee
Fibrillary glomerulonephritis associated with crescents as a therapeutic challenge.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(2):420-5.
2002: Sylvia Stracke; Klaus Konner; Isabella Köstlin; Reinhard Friedl; Peter M Jehle; Vinzenz Hombach; Frieder Keller; Johannes Waltenberger
Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas.
Kidney international 2002;61(3):1011-9.
2002: Frieder Keller; M Giehl; David Czock; D Zellner
PK-PD curve-fitting problems with the Hill equation? Try one of the 1-exp functions derived from Hodgkin, Douglas or Gompertz.
International journal of clinical pharmacology and therapeutics 2002;40(1):23-9.
2001: F Ernst; S Hetzel; Sylvia Stracke; David Czock; G Vargas; Manfred P Lutz; Frieder Keller; Peter M Jehle
Renal proximal tubular cell growth and differentiation are differentially modulated by renotropic growth factors and tyrosine kinase inhibitors.
European journal of clinical investigation 2001;31(12):1029-39.
2001: D Zellner; G E Zellner; Frieder Keller
A SAS macro for sample size re-estimation.
Computer methods and programs in biomedicine 2001;65(3):183-90.
2000: David Czock; M Giehl; Frieder Keller
A concept for pharmacokinetic-pharmacodynamic dosage adjustment in renal impairment: the case of aminoglycosides.
Clinical pharmacokinetics 2000;38(4):367-75.
2000: M S Wagner; Sylvia Stracke; Peter M Jehle; Frieder Keller; D Zellner; David J Baylink; Subburaman Mohan
Evaluation of IGF system component levels and mitogenic activity of uremic serum on normal human osteoblasts.
Nephron 2000;84(2):158-66.
2000: Peter M Jehle; A Ostertag; K Schulten; W Schulz; DR Jehle; Sylvia Stracke; R Fiedler; Heinz J Deuber; Frieder Keller; Bernhard O Boehm; David J Baylink; Subburaman Mohan
Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Kidney international 2000;57(2):423-36.
1999: U Schöll; U Wastl; Teut Risler; N Braun; Bernd Grabensee; Peter J Heering; Peter Schollmeyer; Ingeborg Zäuner; G Stein; Reinhard Fünfstück; Frieder Keller
The "point of no return" and the rate of progression in the natural history of IgA nephritis.
Clinical nephrology 1999;52(5):285-92.
1999: Frieder Keller; J Böhler; David Czock; D Zellner; Andreas Mertz
Individualized drug dosage in patients treated with continuous hemofiltration.
Kidney international. Supplement 1999;(72):S29-31.
1999: Joachim Böhler; Johannes Donauer; Frieder Keller
Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage.
Kidney international. Supplement 1999;(72):S24-8.
1999: Peter M Jehle; U Aisenpreis; D Bundschu; Frieder Keller
[Advantages of insulin Lispro (short-acting) in terminal kidney failure].
Fortschritte der Medizin 1999;117(11):41-2.
1999: F M Rasche; A Schwarz; Frieder Keller
Tonsillectomy does not prevent a progressive course in IgA nephropathy.
Clinical nephrology 1999;51(3):147-52.
1999: Sylvia Stracke; Peter M Jehle; D Sturm; MH Schoenberg; U Widmaier; Hans G Beger; Frieder Keller
Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;33(2):304-11.
1999: DR Jehle; Frieder Keller; A Schwarz; Peter M Jehle
Hypercalcemia-induced renal insufficiency during therapy with dihydrotachysterol.
Journal of medicine 1999;30(1-2):39-50.
1999: Frieder Keller; David Czock
Pharmacodynamic half-life and effect-time course in renal impairment.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14 Suppl 4():6-8.
1999: U Aisenpreis; A Pfützner; M Giehl; Frieder Keller; Peter M Jehle
Pharmacokinetics and pharmacodynamics of insulin Lispro compared with regular insulin in haemodialysis patients with diabetes mellitus.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14 Suppl 4():5-6.
1999: David Czock; Frieder Keller
The area under the effect-time curve as a target parameter for dosage adaptation in renal insufficiency.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14 Suppl 4():4.
1998: Frieder Keller; David Czock
Pharmacokinetic studies in volunteers with renal impairment.
International journal of clinical pharmacology and therapeutics 1998;36(11):594-8.
1998: D Zellner; T Frankewitsch; Frieder Keller
Synthesis of pharmacokinetic parameters of vancomycin via bootstrap methods.
International journal of clinical pharmacology and therapeutics 1998;36(10):554-60.
1998: Peter M Jehle; Sylvia Stracke; F Ernst; DR Jehle; R Willi Grunewald; H Haller; Frieder Keller
Pleiotropic effects of hepatocyte growth factor in proximal tubule involve different signaling pathways.
Kidney international. Supplement 1998;67():S152-4.
1998: Sylvia Stracke; F Ernst; DR Jehle; R Willi Grunewald; H Haller; Frieder Keller; Peter M Jehle
Differentiating and proliferative effects of HGF in renal proximal tubular cells are mediated via different signalling pathways.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(6):1398-405.
1998: D Zellner; G E Zellner; Frieder Keller
Dependence of vancomycin clearance on renal function via regression and bootstrap methods.
Journal of clinical pharmacy and therapeutics 1998;23(2):107-13.
1998: Frieder Keller; David Czock; D Zellner; M Giehl
Relationship between pharmacokinetic half-life and pharmacodynamic half-life in effect-time modeling.
International journal of clinical pharmacology and therapeutics 1998;36(3):168-75.
1998: Frieder Keller; T Frankewitsch; D Zellner; S Simon; David Czock; M Giehl
Standardized structure and modular design of a pharmacokinetic database.
Computer methods and programs in biomedicine 1998;55(2):107-15.
1998: Peter M Jehle; DR Jehle; Subburaman Mohan; Frieder Keller
Renal osteodystrophy: new insights in pathophysiology and treatment modalities with special emphasis on the insulin-like growth factor system.
Nephron 1998;79(3):249-64.
1997: A Eckhardt; K Borner; Frieder Keller; D Zellner
Dosage adjustment of antiinfective therapy in patients with renal impairment.
International journal of clinical pharmacology and therapeutics 1997;35(3):99-102.
1996: D Zellner; T Schromm; T Frankewitsch; M Giehl; Frieder Keller
Structured data entry for reliable acquisition of pharmacokinetic data.
Methods of information in medicine 1996;35(3):261-4.
1996: Peter M Jehle; R D Fussgänger; Sylvia Stracke; R Willi Grunewald; Frieder Keller
Different binding and degradation of proinsulin, insulin and insulin-like growth factor-1 (IGF-1) in cultured renal proximal tubular cells. Implications for the prolonged serum half-life of proinsulin.
Acta diabetologica 1996;33(2):159-65.
1996: D Zellner; T Frankewitsch; S Simon; Frieder Keller
Statistical analysis of heterogeneous pharmacokinetic data from the literature.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1996;34(7):585-9.
1996: Frieder Keller; D Zellner
The 1-exp function as an alternative model of non-linear saturable kinetics.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1996;34(3):265-71.
1995: Frieder Keller; T Frankewitsch; D Zellner; S Simon
Unifying concept of pharmacokinetics derived from drug distribution and elimination in renal failure.
International journal of clinical pharmacology and therapeutics 1995;33(10):546-9.
1995: Frieder Keller; M Giehl; T Frankewitsch; D Zellner
Pharmacokinetics and drug dosage adjustment to renal impairment.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(9):1516-20.
1994: J Passfall; I Schuller; Frieder Keller
Pharmacokinetics of cyclosporin during administration of danazol.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(12):1807-8.